Ping C. Sun
Department Of Otolaryngology Head And Neck Surgery, Jinan 250022
Jinan, 250022, China
Jinan, 250022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Clinical characteristics and surgical management of primary intralabyrinthine tumor
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: December 22, 2025
Contrast-Enhanced Mammography-Based Radiomics for Predicting Ductal Carcinoma In Situ in Breast Cancer.
Journal: Journal of imaging informatics in medicine
Published: December 17, 2025
The clinical value of repeat ultrasound-guided fine-needle aspiration biopsy in the management of Bethesda Category III thyroid nodules.
Journal: Frontiers in endocrinology
Published: November 20, 2025
Letter to the Editor about "Integrating clinical-pathological-MRI features to construct a prediction model for pathological complete remission of axillary lymph nodes after neoadjuvant therapy: a retrospective study".
Journal: International journal of surgery (London, England)
Published: September 05, 2025
Trastuzumab deruxtecan (DS-8201) plus bevacizumab for HER2-low metastatic breast cancer with malignant pleural effusion: a case report and literature review.
Journal: Frontiers in oncology
Published: August 28, 2025
Amivantamab plus chemotherapy vs. chemotherapy as first-line treatment in Chinese mainland patients with EGFR exon 20 insertion non-small cell lung cancer: Subgroup analysis of the randomized PAPILLON trial.
Journal: Chinese medical journal
Published: August 12, 2025
Real-World Efficacy of Cadonilimab Plus Chemotherapy as Second-Line Therapy in Immunotherapy-Pretreated Advanced HER2 Negative Gastric or Gastroesophageal Junction Cancer.
Journal: Drug design, development and therapy
Published: July 09, 2025
Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study.
Journal: Drug design, development and therapy
Published: June 20, 2025
A multicenter randomized controlled trial of intrapleural perfusion of methotrexate-loaded tumor cell-derived microparticles combined with systemic therapy for malignant pleural effusion.
Journal: International journal of cancer
Published: May 21, 2025
PLCH1 overexpression promotes breast cancer progression and predicts poor prognosis through the ERK1/2-EGR1 axis.
Journal: Frontiers in oncology
Published: February 15, 2025
Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study.
Journal: Drug design, development and therapy
Published: January 10, 2025
Clinical application value of targeted amplicon sequencing technology in fetuses with uniparental disomy-related imprinting disorders: a multicenter study.
Journal: Journal of translational medicine
Published: January 03, 2025
Last Updated: 09/26/2026